MedTrace Logo

Prospective, Longitudinal Natural History Study in Dystrophic Epidermolysis Bullosa

NCT01768026 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2013-05-21

No results posted yet for this study

Summary

The objective of this study is to characterize the extent and severity of disease in subjects with DEB and the progression of disease over a timeframe relevant to interventional studies. The data from this study will be used to inform the study design and address statistical considerations of future treatment protocols.

Conditions

  • Dystrophic Epidermolysis Bullosa

Sponsors & Collaborators

  • Lotus Tissue Repair, Inc.

    lead INDUSTRY

Principal Investigators

  • Hal Landy, MD · Lotus Tissue Repair, Inc.

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01768026 on ClinicalTrials.gov